本可行性研究的主要目的是使用顺序多重评估随机对照试验（ SMART ）设计，评估适应性阶梯式护理干预措施在改善中国轻度至中度睡眠障碍癌症患者睡眠质量方面的可行性和可接受性，以及潜在的临床意义。
适应症：Neoplasm、Sleep Disturbance
入组条件
纳入标准
- Cantonese- or Mandarin-speaking Chinese patients diagnosed with curable breast, colorectal, or gynaecological cancer
- Completed treatment (except endocrine therapy) within two years
- Presenting with Pittsburgh Sleep Quality Index (PSQI) score of 6 to 11 indicating mild-to-moderate sleep disturbance
排除标准
- Diagnosis of metastatic cancer
- Current diagnosis of psychiatric disorder
- Current diagnosis of another sleep disorder,
- Have received psychological treatment specifically for sleep disturbance
入组条件维持 ClinicalTrials.gov 原始英文登记资料，实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源：ClinicalTrials.gov，每两周自动更新，最后同步：2026年10月8日。